Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study

The ‘Individualized Therapy for Relapsed Malignancies in Childhood’ (INFORM) precision medicine study is a nationwide German program for children with high-risk relapsed/refractory malignancies, which aims to identify therapeutic targets on an individualised basis. In a pilot phase, reported here, w...

Full description

Saved in:
Bibliographic Details
Main Authors: Jones, Barbara Christine (Author) , Tilburg, Cornelis M. van (Author) , Balasubramanian, Gnana Prakash (Author) , Fiesel, Petra (Author) , Witt, Ruth (Author) , Freitag, Angelika (Author) , Boudalil, Miream (Author) , Hutter, Barbara (Author) , Taylor, Lenka A. (Author) , Sutter, Christian (Author) , Bartram, Claus R. (Author) , Milde, Till (Author) , Pfaff, Elke (Author) , Kulozik, Andreas (Author) , Brors, Benedikt (Author) , Deimling, Andreas von (Author) , Capper, David (Author) , Pfister, Stefan (Author) , Witt, Olaf (Author)
Format: Article (Journal)
Language:English
Published: 29 July 2016
In: European journal of cancer
Year: 2016, Volume: 65, Pages: 91-101
ISSN:1879-0852
DOI:10.1016/j.ejca.2016.06.009
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2016.06.009
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0959804916322122
Get full text
Author Notes:Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian, Petra Fiesel, Ruth Witt, Angelika Freitag, Miream Boudalil, Christopher Previti, Stephan Wolf, Sabine Schmidt, Sasithorn Chotewutmontri, Melanie Bewerunge-Hudler, Matthias Schick, Matthias Schlesner, Barbara Hutter, Lenka Taylor, Tobias Borst, Christian Sutter, Claus R. Bartram, Till Milde, Elke Pfaff, Andreas E. Kulozik, Arend von Stackelberg, Roland Meisel, Arndt Borkhardt, Dirk Reinhardt, Jan-Henning Klusmann, Gudrun Fleischhack, Stephan Tippelt, Uta Dirksen, Heribert Jürgens, Christof M. Kramm, Andre O. von Bueren, Frank Westermann, Matthias Fischer, Birgit Burkhardt, Wilhelm Wößmann, Michaela Nathrath, Stefan S. Bielack, Michael C. Frühwald, Simone Fulda, Thomas Klingebiel, Ewa Koscielniak, Matthias Schwab, Roman Tremmel, Pablo Hernáiz Driever, Johannes H. Schulte, Benedikt Brors, Andreas von Deimling, Peter Lichter, Angelika Eggert, David Capper, Stefan M. Pfister, David T.W. Jones, Olaf Witt

MARC

LEADER 00000caa a2200000 c 4500
001 1567884881
003 DE-627
005 20240316100320.0
007 cr uuu---uuuuu
008 180131s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2016.06.009  |2 doi 
035 |a (DE-627)1567884881 
035 |a (DE-576)497884887 
035 |a (DE-599)BSZ497884887 
035 |a (OCoLC)1340986207 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
100 1 |a Jones, Barbara Christine  |d 1986-  |e VerfasserIn  |0 (DE-588)1078243352  |0 (DE-627)838187226  |0 (DE-576)449711331  |4 aut 
245 1 0 |a Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study  |c Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian, Petra Fiesel, Ruth Witt, Angelika Freitag, Miream Boudalil, Christopher Previti, Stephan Wolf, Sabine Schmidt, Sasithorn Chotewutmontri, Melanie Bewerunge-Hudler, Matthias Schick, Matthias Schlesner, Barbara Hutter, Lenka Taylor, Tobias Borst, Christian Sutter, Claus R. Bartram, Till Milde, Elke Pfaff, Andreas E. Kulozik, Arend von Stackelberg, Roland Meisel, Arndt Borkhardt, Dirk Reinhardt, Jan-Henning Klusmann, Gudrun Fleischhack, Stephan Tippelt, Uta Dirksen, Heribert Jürgens, Christof M. Kramm, Andre O. von Bueren, Frank Westermann, Matthias Fischer, Birgit Burkhardt, Wilhelm Wößmann, Michaela Nathrath, Stefan S. Bielack, Michael C. Frühwald, Simone Fulda, Thomas Klingebiel, Ewa Koscielniak, Matthias Schwab, Roman Tremmel, Pablo Hernáiz Driever, Johannes H. Schulte, Benedikt Brors, Andreas von Deimling, Peter Lichter, Angelika Eggert, David Capper, Stefan M. Pfister, David T.W. Jones, Olaf Witt 
264 1 |c 29 July 2016 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.01.2018 
520 |a The ‘Individualized Therapy for Relapsed Malignancies in Childhood’ (INFORM) precision medicine study is a nationwide German program for children with high-risk relapsed/refractory malignancies, which aims to identify therapeutic targets on an individualised basis. In a pilot phase, reported here, we developed the logistical and analytical pipelines necessary for rapid and comprehensive molecular profiling in a clinical setting. Fifty-seven patients from 20 centers were prospectively recruited. Malignancies investigated included sarcomas (n = 25), brain tumours (n = 23), and others (n = 9). Whole-exome, low-coverage whole-genome, and RNA sequencing were complemented with methylation and expression microarray analyses. Alterations were assessed for potential targetability according to a customised prioritisation algorithm and subsequently discussed in an interdisciplinary molecular tumour board. Next-generation sequencing data were generated for 52 patients, with the full analysis possible in 46 of 52. Turnaround time from sample receipt until first report averaged 28 d. Twenty-six patients (50%) harbored a potentially druggable alteration with a prioritisation score of ‘intermediate’ or higher (level 4 of 7). Common targets included receptor tyrosine kinases, phosphoinositide 3-kinase-mammalian target of rapamycin pathway, mitogen-activated protein kinase pathway, and cell cycle control. Ten patients received a targeted therapy based on these findings, with responses observed in some previously treatment-refractory tumours. Comparative primary relapse analysis revealed substantial tumour evolution as well as one case of unsuspected secondary malignancy, highlighting the importance of re-biopsy at relapse. This study demonstrates the feasibility of comprehensive, real-time molecular profiling for high-risk paediatric cancer patients. This extended proof-of-concept, with examples of treatment consequences, expands upon previous personalised oncology endeavors, and presents a model with considerable interest and practical relevance in the burgeoning era of personalised medicine. 
650 4 |a Brain 
650 4 |a Cancer 
650 4 |a Deep sequencing 
650 4 |a Molecular targeted therapy 
650 4 |a Oncology 
650 4 |a Paediatrics 
650 4 |a Personalised medicine 
650 4 |a Precision medicine 
650 4 |a Sarcoma 
700 1 |a Tilburg, Cornelis M. van  |e VerfasserIn  |0 (DE-588)1144664527  |0 (DE-627)1004962355  |0 (DE-576)495479519  |4 aut 
700 1 |a Balasubramanian, Gnana Prakash  |d 1981-  |e VerfasserIn  |0 (DE-588)14362671X  |0 (DE-627)647708922  |0 (DE-576)338051554  |4 aut 
700 1 |a Fiesel, Petra  |e VerfasserIn  |0 (DE-588)1151579866  |0 (DE-627)101192353X  |0 (DE-576)497883740  |4 aut 
700 1 |a Witt, Ruth  |e VerfasserIn  |0 (DE-588)115142076X  |0 (DE-627)1011646536  |0 (DE-576)497741776  |4 aut 
700 1 |a Freitag, Angelika  |e VerfasserIn  |0 (DE-588)1151580295  |0 (DE-627)1011924056  |0 (DE-576)497884690  |4 aut 
700 1 |a Boudalil, Miream  |e VerfasserIn  |0 (DE-588)115158052X  |0 (DE-627)1011924315  |0 (DE-576)497884593  |4 aut 
700 1 |a Hutter, Barbara  |e VerfasserIn  |0 (DE-588)14009752X  |0 (DE-627)61602293X  |0 (DE-576)314588760  |4 aut 
700 1 |a Taylor, Lenka A.  |e VerfasserIn  |0 (DE-588)138997853  |0 (DE-627)70317570X  |0 (DE-576)30938821X  |4 aut 
700 1 |a Sutter, Christian  |e VerfasserIn  |0 (DE-588)1067529160  |0 (DE-627)818862068  |0 (DE-576)42671993X  |4 aut 
700 1 |a Bartram, Claus R.  |d 1952-  |e VerfasserIn  |0 (DE-588)139758518  |0 (DE-627)613089502  |0 (DE-576)312997159  |4 aut 
700 1 |a Milde, Till  |d 1973-  |e VerfasserIn  |0 (DE-588)1038311837  |0 (DE-627)75711234X  |0 (DE-576)39229334X  |4 aut 
700 1 |a Pfaff, Elke  |d 1985-  |e VerfasserIn  |0 (DE-588)1037262174  |0 (DE-627)755739728  |0 (DE-576)39127614X  |4 aut 
700 1 |a Kulozik, Andreas  |d 1959-  |e VerfasserIn  |0 (DE-588)1025736567  |0 (DE-627)723892032  |0 (DE-576)167091638  |4 aut 
700 1 |a Brors, Benedikt  |e VerfasserIn  |0 (DE-588)1112102965  |0 (DE-627)866068732  |0 (DE-576)476376157  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Capper, David  |d 1979-  |e VerfasserIn  |0 (DE-588)133950751  |0 (DE-627)558829902  |0 (DE-576)300212402  |4 aut 
700 1 |a Pfister, Stefan  |d 1974-  |e VerfasserIn  |0 (DE-588)123850215  |0 (DE-627)706450930  |0 (DE-576)293908400  |4 aut 
700 1 |a Witt, Olaf  |d 1965-  |e VerfasserIn  |0 (DE-588)17275030X  |0 (DE-627)697681750  |0 (DE-576)133607410  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 65(2016), Seite 91-101  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study 
773 1 8 |g volume:65  |g year:2016  |g pages:91-101  |g extent:11  |a Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study 
856 4 0 |u http://dx.doi.org/10.1016/j.ejca.2016.06.009  |x Verlag  |x Resolving-System  |3 Volltext  |7 1 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0959804916322122  |x Verlag  |3 Volltext  |7 1 
951 |a AR 
992 |a 20180131 
992 |a 20180131 
993 |a Article 
993 |a Article 
994 |a 2016 
994 |a 2016 
998 |g 17275030X  |a Witt, Olaf  |m 17275030X:Witt, Olaf  |d 910000  |d 910500  |e 910000PW17275030X  |e 910500PW17275030X  |k 0/910000/  |k 1/910000/910500/  |p 55  |y j 
998 |g 123850215  |a Pfister, Stefan  |m 123850215:Pfister, Stefan  |d 910000  |d 910500  |e 910000PP123850215  |e 910500PP123850215  |k 0/910000/  |k 1/910000/910500/  |p 53 
998 |g 133950751  |a Capper, David  |m 133950751:Capper, David  |d 910000  |d 912000  |e 910000PC133950751  |e 912000PC133950751  |k 0/910000/  |k 1/910000/912000/  |p 52 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 49 
998 |g 1112102965  |a Brors, Benedikt  |m 1112102965:Brors, Benedikt  |d 140000  |e 140000PB1112102965  |k 0/140000/  |p 48 
998 |g 1025736567  |a Kulozik, Andreas  |m 1025736567:Kulozik, Andreas  |d 910000  |d 910500  |e 910000PK1025736567  |e 910500PK1025736567  |k 0/910000/  |k 1/910000/910500/  |p 22 
998 |g 1037262174  |a Pfaff, Elke  |m 1037262174:Pfaff, Elke  |d 910000  |d 910500  |e 910000PP1037262174  |e 910500PP1037262174  |k 0/910000/  |k 1/910000/910500/  |p 21 
998 |g 1038311837  |a Milde, Till  |m 1038311837:Milde, Till  |d 910000  |d 910500  |e 910000PM1038311837  |e 910500PM1038311837  |k 0/910000/  |k 1/910000/910500/  |p 20 
998 |g 139758518  |a Bartram, Claus R.  |m 139758518:Bartram, Claus R.  |d 910000  |d 911500  |e 910000PB139758518  |e 911500PB139758518  |k 0/910000/  |k 1/910000/911500/  |p 19 
998 |g 1067529160  |a Sutter, Christian  |m 1067529160:Sutter, Christian  |d 910000  |d 911500  |e 910000PS1067529160  |e 911500PS1067529160  |k 0/910000/  |k 1/910000/911500/  |p 18 
998 |g 138997853  |a Taylor, Lenka A.  |m 138997853:Taylor, Lenka A.  |d 50000  |d 54600  |e 50000PT138997853  |e 54600PT138997853  |k 0/50000/  |k 1/50000/54600/  |p 16 
998 |g 14009752X  |a Hutter, Barbara  |m 14009752X:Hutter, Barbara  |d 140000  |e 140000PH14009752X  |k 0/140000/  |p 15 
998 |g 115158052X  |a Boudalil, Miream  |m 115158052X:Boudalil, Miream  |d 910000  |d 912000  |e 910000PB115158052X  |e 912000PB115158052X  |k 0/910000/  |k 1/910000/912000/  |p 7 
998 |g 1151580295  |a Freitag, Angelika  |m 1151580295:Freitag, Angelika  |d 910000  |e 910000PF1151580295  |k 0/910000/  |p 6 
998 |g 115142076X  |a Witt, Ruth  |m 115142076X:Witt, Ruth  |d 910000  |e 910000PW115142076X  |k 0/910000/  |p 5 
998 |g 1151579866  |a Fiesel, Petra  |m 1151579866:Fiesel, Petra  |d 910000  |d 911100  |e 910000PF1151579866  |e 911100PF1151579866  |k 0/910000/  |k 1/910000/911100/  |p 4 
998 |g 14362671X  |a Balasubramanian, Gnana Prakash  |m 14362671X:Balasubramanian, Gnana Prakash  |d 910000  |e 910000PB14362671X  |k 0/910000/  |p 3 
998 |g 1144664527  |a Tilburg, Cornelis M. van  |m 1144664527:Tilburg, Cornelis M. van  |d 910000  |d 910500  |e 910000PT1144664527  |e 910500PT1144664527  |k 0/910000/  |k 1/910000/910500/  |p 2 
998 |g 1078243352  |a Jones, Barbara Christine  |m 1078243352:Jones, Barbara Christine  |d 910000  |d 910500  |e 910000PJ1078243352  |e 910500PJ1078243352  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1567884881  |e 2994764741 
999 |a KXP-PPN1567884881  |e 2994735075 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"11 S."}],"title":[{"title_sort":"Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study","title":"Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study"}],"language":["eng"],"name":{"displayForm":["Barbara C. Worst, Cornelis M. van Tilburg, Gnana Prakash Balasubramanian, Petra Fiesel, Ruth Witt, Angelika Freitag, Miream Boudalil, Christopher Previti, Stephan Wolf, Sabine Schmidt, Sasithorn Chotewutmontri, Melanie Bewerunge-Hudler, Matthias Schick, Matthias Schlesner, Barbara Hutter, Lenka Taylor, Tobias Borst, Christian Sutter, Claus R. Bartram, Till Milde, Elke Pfaff, Andreas E. Kulozik, Arend von Stackelberg, Roland Meisel, Arndt Borkhardt, Dirk Reinhardt, Jan-Henning Klusmann, Gudrun Fleischhack, Stephan Tippelt, Uta Dirksen, Heribert Jürgens, Christof M. Kramm, Andre O. von Bueren, Frank Westermann, Matthias Fischer, Birgit Burkhardt, Wilhelm Wößmann, Michaela Nathrath, Stefan S. Bielack, Michael C. Frühwald, Simone Fulda, Thomas Klingebiel, Ewa Koscielniak, Matthias Schwab, Roman Tremmel, Pablo Hernáiz Driever, Johannes H. Schulte, Benedikt Brors, Andreas von Deimling, Peter Lichter, Angelika Eggert, David Capper, Stefan M. Pfister, David T.W. Jones, Olaf Witt"]},"note":["Gesehen am 31.01.2018"],"recId":"1567884881","id":{"eki":["1567884881"],"doi":["10.1016/j.ejca.2016.06.009"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"29 July 2016"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","family":"Jones","display":"Jones, Barbara Christine","given":"Barbara Christine"},{"given":"Cornelis M. van","display":"Tilburg, Cornelis M. van","family":"Tilburg","role":"aut"},{"display":"Balasubramanian, Gnana Prakash","family":"Balasubramanian","role":"aut","given":"Gnana Prakash"},{"family":"Fiesel","display":"Fiesel, Petra","role":"aut","given":"Petra"},{"given":"Ruth","display":"Witt, Ruth","family":"Witt","role":"aut"},{"role":"aut","display":"Freitag, Angelika","family":"Freitag","given":"Angelika"},{"given":"Miream","display":"Boudalil, Miream","family":"Boudalil","role":"aut"},{"family":"Hutter","display":"Hutter, Barbara","role":"aut","given":"Barbara"},{"role":"aut","family":"Taylor","display":"Taylor, Lenka A.","given":"Lenka A."},{"given":"Christian","role":"aut","family":"Sutter","display":"Sutter, Christian"},{"given":"Claus R.","role":"aut","display":"Bartram, Claus R.","family":"Bartram"},{"given":"Till","role":"aut","family":"Milde","display":"Milde, Till"},{"family":"Pfaff","display":"Pfaff, Elke","role":"aut","given":"Elke"},{"role":"aut","family":"Kulozik","display":"Kulozik, Andreas","given":"Andreas"},{"role":"aut","family":"Brors","display":"Brors, Benedikt","given":"Benedikt"},{"given":"Andreas von","role":"aut","family":"Deimling","display":"Deimling, Andreas von"},{"given":"David","family":"Capper","display":"Capper, David","role":"aut"},{"role":"aut","family":"Pfister","display":"Pfister, Stefan","given":"Stefan"},{"role":"aut","family":"Witt","display":"Witt, Olaf","given":"Olaf"}],"relHost":[{"titleAlt":[{"title":"EJC online"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"266883400","disp":"Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyEuropean journal of cancer","part":{"pages":"91-101","volume":"65","text":"65(2016), Seite 91-101","year":"2016","extent":"11"},"pubHistory":["28.1992 -"],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"role":"isb","display":"European School of Oncology"}],"origin":[{"publisher":"Elsevier ; Pergamon Press","dateIssuedKey":"1992","dateIssuedDisp":"1992-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]"}],"id":{"eki":["266883400"],"zdb":["1468190-0"],"issn":["1879-0852"]},"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"language":["eng"]}]} 
SRT |a JONESBARBANEXTGENERA2920